Open-label placebos as adjunctive therapy for patients with depression

BACKGROUND: Placebos prescribed as ‘regular’ medication can reduce symptoms of depression. However, using a placebo without patients' informed consent presents ethical issues. Therefore, the present study assessed the efficacy of an open-label placebo (OLP), which was administered concurrently...

Descripción completa

Detalles Bibliográficos
Autores principales: Schienle, Anne, Jurinec, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228278/
https://www.ncbi.nlm.nih.gov/pubmed/35754973
http://dx.doi.org/10.1016/j.conctc.2022.100948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228278/
https://www.ncbi.nlm.nih.gov/pubmed/35754973
http://dx.doi.org/10.1016/j.conctc.2022.100948

Ejemplares similares